Clinical Trials Consumption Events Patients 
Cannabis Law Report
JUNE 1, 2021
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.
Veriheal
MAY 3, 2022
If having an MMJ card has adverse impacts on consumption, the public has a right to know; at the same time, the convoluted nature of the research makes it very easy to misinterpret and misunderstand the findings. Clinical Trial Sample Size. a necessary question to address as medical marijuana becomes more accessible.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
MARCH 8, 2020
In January of 2020, the Journal of the American College of Cardiology published a review titled Marijuana Use in Patients With Cardiovascular Disease. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. a heart attack). population, has an arrhythmia.
The Cannigma
MAY 19, 2021
Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes. Shutterstock).
The Joint Blog
MARCH 18, 2021
According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS). Additional information on cannabis and PTSD is available from NORML.
Veriheal
JUNE 7, 2021
Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.
Cannabis Law Report
OCTOBER 12, 2021
Their audacious vision to reimagine traditional pharma efficacy trials promises to rapidly and accurately determine which nutraceuticals and natural molecules actually work for which conditions,” said Diamandis. Radicle Science also announced a new CTO, Sheldon Borkin , PhD, who joined in September 2021.
Expert insights. Personalized for you.
89 
Let's personalize your content